These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 14981912
21. Mechanism of growth inhibitory effects of cyclooxygenase-2 inhibitor-NS398 on cancer cells. Li S, Tong Q, Zhang W, Wang Q, Chen Z, Wu Q. Cancer Invest; 2008 May; 26(4):333-7. PubMed ID: 18443952 [Abstract] [Full Text] [Related]
23. NS-398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines. Cheng J, Imanishi H, Amuro Y, Hada T. Int J Cancer; 2002 Jun 10; 99(5):755-61. PubMed ID: 12115513 [Abstract] [Full Text] [Related]
24. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor. Hasegawa K, Ohashi Y, Ishikawa K, Yasue A, Kato R, Achiwa Y, Nishio E, Udagawa Y. Int J Oncol; 2005 May 10; 26(5):1419-28. PubMed ID: 15809736 [Abstract] [Full Text] [Related]
25. COX-2 correlates with F-box protein, Skp2 expression and prognosis in human gastric carcinoma. Honjo S, Kase S, Osaki M, Ardyanto TD, Kaibara N, Ito H. Int J Oncol; 2005 Feb 10; 26(2):353-60. PubMed ID: 15645119 [Abstract] [Full Text] [Related]
26. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines. Uefuji K, Ichikura T, Shinomiya N, Mochizuki H. Anticancer Res; 2000 Feb 10; 20(6B):4279-84. PubMed ID: 11205258 [Abstract] [Full Text] [Related]
32. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. Liu X, Yue P, Zhou Z, Khuri FR, Sun SY. J Natl Cancer Inst; 2004 Dec 01; 96(23):1769-80. PubMed ID: 15572759 [Abstract] [Full Text] [Related]
34. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126. Gao J, Niwa K, Takemura M, Sun W, Onogi K, Wu Y, Seishima M, Mori H, Tamaya T. Int J Oncol; 2005 Mar 01; 26(3):737-44. PubMed ID: 15703831 [Abstract] [Full Text] [Related]
35. Effects of cyclooxygenase 2 inhibitors on biological traits of nasopharyngeal carcinoma cells. Chen PY, Long QC. Acta Pharmacol Sin; 2004 Jul 01; 25(7):943-9. PubMed ID: 15210070 [Abstract] [Full Text] [Related]
36. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies. Chen WC, McBride WH, Chen SM, Lee KF, Hwang TZ, Jung SM, Shau H, Liao SK, Hong JH, Chen MF. Head Neck; 2005 Jun 01; 27(6):503-12. PubMed ID: 15772955 [Abstract] [Full Text] [Related]
38. Inhibition of cyclooxygenase-2 with NS-398 and the prevention of radiation-induced transformation, micronuclei formation and clonogenic cell death in C3H 10T1/2 cells. Bisht KS, Bradbury CM, Zoberi I, Curry HA, Kaushal A, Roti Roti JL, Gius D. Int J Radiat Biol; 2003 Nov 01; 79(11):879-88. PubMed ID: 14698956 [Abstract] [Full Text] [Related]
39. Selective COX-2 inhibitor, NS-398, inhibits the replicative senescence of cultured dermal fibroblasts. Han JH, Roh MS, Park CH, Park KC, Cho KH, Kim KH, Eun HC, Chung JH. Mech Ageing Dev; 2004 May 01; 125(5):359-66. PubMed ID: 15130753 [Abstract] [Full Text] [Related]